Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

Is Viatris Stock Underperforming the Nasdaq?

With a market cap of $11.3 billion, Viatris Inc. (VTRS) is a global pharmaceutical company headquartered in Pennsylvania with operations in over 165 countries. Its portfolio spans generic and branded medicines, biosimilars, and APIs, covering key therapeutic areas like cardiovascular, oncology, CNS, women’s health, and gastroenterology. 

Companies worth $10 billion or more are generally described as "large-cap stocks." Viatris fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the specialty & generic drug manufacturing industry. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.